Tenet Healthcare (NYSE:THC) Issues FY 2019 Earnings Guidance

Tenet Healthcare (NYSE:THC) updated its FY 2019 earnings guidance on Monday. The company provided EPS guidance of $2.08-2.59 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.36. The company issued revenue guidance of $18-18.4 billion, compared to the consensus revenue estimate of $18.19 billion.Tenet Healthcare also updated its FY19 guidance to $2.08-2.59 EPS.

Several equities research analysts have recently issued reports on the company. TheStreet lowered Tenet Healthcare from a c rating to a d+ rating in a research report on Monday, May 13th. Barclays set a $24.00 price objective on shares of Tenet Healthcare and gave the company a hold rating in a research report on Wednesday, April 17th. ValuEngine downgraded shares of Tenet Healthcare from a sell rating to a strong sell rating in a research report on Wednesday, May 1st. Finally, SunTrust Banks reduced their price objective on shares of Tenet Healthcare to $27.00 and set a hold rating for the company in a research report on Wednesday, May 1st. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus price target of $29.46.

Shares of THC traded down $0.25 during mid-day trading on Monday, reaching $22.10. 1,170,990 shares of the company’s stock were exchanged, compared to its average volume of 1,566,218. The company has a debt-to-equity ratio of 21.98, a quick ratio of 1.15 and a current ratio of 1.23. The stock’s 50-day simple moving average is $20.25. Tenet Healthcare has a 52-week low of $16.60 and a 52-week high of $39.39. The company has a market cap of $2.31 billion, a P/E ratio of 11.88, a price-to-earnings-growth ratio of 0.62 and a beta of 1.65.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.56 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.12. Tenet Healthcare had a negative net margin of 0.04% and a positive return on equity of 29.29%. The business had revenue of $4.56 billion during the quarter, compared to analysts’ expectations of $4.48 billion. During the same period last year, the company posted $0.49 EPS. The company’s revenue was up 1.2% on a year-over-year basis. On average, equities research analysts predict that Tenet Healthcare will post 2.33 EPS for the current fiscal year.

In other news, major shareholder Glenview Capital Management, L bought 27,424 shares of the stock in a transaction on Friday, July 26th. The stock was purchased at an average cost of $20.99 per share, with a total value of $575,629.76. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.50% of the stock is currently owned by insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also: What is an overbought condition?

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.